Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | GBA1 | P04062 | 2/20 | 0.55 |
| ▸ | UGCG | Q16739 | 2/20 | 0.55 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.55 |
| ▸ | POLA1 | P09884 | 1/20 | 0.52 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.50 |
| ▸ | CYP46A1 | Q9Y6A2 | 2/20 | 0.49 |
| ▸ | HPSE | Q9Y251 | 4/20 | 0.48 |
| ▸ | FGF1 | P05230 | 3/20 | 0.48 |
| ▸ | FGF2 | P09038 | 3/20 | 0.48 |
| ▸ | OSBP | P22059 | 2/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.48 |
| ▸ | RORC | P51449 | 1/20 | 0.48 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.48 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.46 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.45 |
| ▸ | APP | P05067 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23601842 | 1.00 | POLB (0.56) | POLBGBA1UGCGGBA2POLA1 | |
| SCHEMBL23601691 | 0.89 | POLB (0.49) | POLBGBA1UGCGGBA2POLA1 | |
| SCHEMBL23614817 | 0.87 | HPSE (0.61) | POLA1HPSEFGF1FGF2LGALS3 | |
| SCHEMBL13964924 | 0.81 | POLB (0.62) | POLBGBA1UGCGGBA2POLA1 | |
| SCHEMBL13469722 | 0.81 | POLB (0.62) | POLBGBA1UGCGGBA2POLA1 | |
| Cholesterol Glycoside SCHEMBL5953321 | 0.81 | POLB (0.80) | POLBGBA1UGCGGBA2POLA1 | |
| Cholesterol Glycoside SCHEMBL2838242 | 0.81 | POLB (0.80) | POLBGBA1UGCGGBA2POLA1 | |
| Cholesterol Glycoside SCHEMBL1357529 | 0.81 | POLB (0.80) | POLBGBA1UGCGGBA2POLA1 | |
| Cholesterol Glycoside SCHEMBL5257698 | 0.81 | POLB (0.80) | POLBGBA1UGCGGBA2POLA1 | |
| Cholesterol Glycoside SCHEMBL12695652 | 0.81 | POLB (0.80) | POLBGBA1UGCGGBA2POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210196832-A1 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | CHENGDU RIBOCURE PHARMATECH COMPANY LIMITED (CN) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210196832-A1 | TARGETED NANOPREPARATION OF MANNOSE, AND PREPARATION THEREFOR AND APPLICATION THEREOF | M6PR, IGF2R, MAN2A1 | POLB 4649/4885GBA1 973/4885UGCG 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.